1,586 results on '"Chun, Felix K. H."'
Search Results
2. Adult Prostate Sarcoma: Demographics, Treatment Patterns, and Survival
3. Radiotherapy Versus Partial Penectomy for T1 Squamous Cell Carcinoma of the Penis
4. Geschlechtsspezifische Unterschiede im chirurgischen Selbstvertrauen: Ergebnisse des Endo-Workshops der German Society of Residents in Urology 2022
5. Race/Ethnicity Affects Access and Survival Differences After Neoadjuvant or Adjuvant Chemotherapy at Radical Cystectomy in Urothelial Carcinoma Patients
6. Aktueller Behandlungsstandard und Trends der Systemtherapie beim metastasierten hormonsensiblen Prostatakarzinom – Anwendung der Studiendaten in der Praxis
7. Differences in life expectancy of adrenocortical carcinoma patients vs. age‑ and sex-matched population controls
8. Sarcomatoid Dedifferentiation as a Predictor of Cancer-Specific Mortality in Surgically Treated Localized Renal Cell Carcinoma
9. Perioperative Complications and In-Hospital Mortality in Partial and Radical Nephrectomy Patients with Heart-Valve Replacement
10. Fluoreszenzbasierte Konfokalmikroskopie – vollständige Digitalisierung der Pathologie
11. ASO Author Reflections: Survival Benefit of Adjuvant Systemic Therapy After Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma
12. Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients
13. Contemporary validation of cT1a vs. cT1b substaging of incidental prostate cancer
14. Cancer-specific mortality in non-metastatic T1a renal cell carcinoma treated with radiotherapy versus partial nephrectomy
15. Thulium fiber laser vs. holmium laser enucleation of the prostate: results of a prospective randomized non-inferiority trial
16. The effect of race/ethnicity on cancer-specific mortality after trimodal therapy
17. Erste klinische und onkologische Erfahrungen mit der Triplet-Therapie beim „high-volume“ metastasierten hormonsensiblen Prostatakarzinom
18. Prognostic Significance of Pathologic Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era
19. In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urologic Cancer Surgery
20. Differences in future life expectancy of testicular germ-cell tumor patients vs. age-matched male population-based controls
21. Regional differences in clear cell metastatic renal cell carcinoma patients across the USA
22. ASO Visual Abstract: Prognostic Significance of Pathological Lymph Node Invasion in Metastatic Renal Cell Carcinoma in the Immunotherapy Era
23. Histopathologic, Molecular, and Clinical Profiling of Lymphoepithelioma-like Carcinoma of the Bladder
24. Comparison of peri- and intraoperative outcomes of open vs robotic-assisted partial nephrectomy for renal cell carcinoma: a propensity-matched analysis
25. Tumor-associated macrophages and Tregs influence and represent immune cell infiltration of muscle-invasive bladder cancer and predict prognosis
26. Differences in overall survival of T2N0M0 bladder cancer patients vs. population-based controls according to treatment modalities
27. Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer
28. European Association of Urology Biochemical Recurrence Risk Classification as a Decision Tool for Salvage Radiotherapy—A Multicenter Study
29. Correction: Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
30. ASO Visual Abstract: In-Hospital Venous Thromboembolism and Pulmonary Embolism After Major Urological Cancer Surgery
31. Chemotherapie ± Androgenrezeptorantagonisten beim metastasierten hormonsensitiven Prostatakarzinom
32. Race/Ethnicity may be an Important Predictor of Life Expectancy in Localized Prostate Cancer Patients: Novel Analyses Using Social Security Administration Life Tables
33. Full functional-length urethral sphincter- and neurovascular bundle preservation improves long-term continence rates after robotic-assisted radical prostatectomy
34. Effect of inguinal lymph node dissection in lymph node negative patients with squamous cell carcinoma of the penis
35. Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity
36. Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patients
37. The significance of the extent of tissue embedding for the detection of incidental prostate carcinoma on transurethral prostate resection material: the more, the better?
38. Improved Survival in Contemporary Community-Based Patients With Metastatic Clear-Cell Renal Cell Carcinoma Undergoing Active Treatment
39. Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care Center
40. Access to trimodal therapy in muscle-invasive bladder cancer is lower in unmarried females
41. PD23-06 SURVIVAL DIFFERENCES BETWEEN PHEOCHROMOCYTOMA AND PARAGANGLIOMA PATIENTS
42. MP01-01 INCREMENTAL DOSE-RESPONSE EFFECT OF AGE ON MORTALITY IN NON-SEMINOMA TESTIS CANCER PATIENTS
43. MP22-07 CONTEMPORARY CONDITIONAL CANCER-SPECIFIC SURVIVAL RATES IN SURGICALLY TREATED NON-METASTATIC PRIMARY URETHRAL CARCINOMA
44. Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicity
45. Plasmacytoid variant urothelial carcinoma of the bladder: effect of radical cystectomy and chemotherapy in non-metastatic and metastatic patients
46. Radiation therapy after radical prostatectomy is associated with higher other-cause mortality
47. Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
48. Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone‐sensitive prostate cancer.
49. Trimodal therapy effect on survival in urothelial vs non‐urothelial bladder cancer.
50. Impact of PSA nadir, PSA response and time to PSA nadir on overall survival in real‐world setting of metastatic hormone‐sensitive prostate cancer patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.